Yingying Xie

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Dna Methylation

Systemic Lupus Erythematosus

Top Venues

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie
Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. Clinical rheumatology 43 (9) (2024)
Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie
Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. Clinical rheumatology 43 (9) (2024)
Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie
Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. Clinical rheumatology 43 (9) (2024)
Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie
Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. Clinical rheumatology 43 (9) (2024)
Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie
Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. Clinical rheumatology 43 (9) (2024)
Yuan Gao, Youtao Zhou, Zikai Lin, Fengzhen Chen, Haiyang Wu, Chusheng Peng, Yingying Xie
Prioritizing drug targets in systemic lupus erythematosus from a genetic perspective: a druggable genome-wide Mendelian randomization study. Clinical rheumatology (2024)